Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02921542 · ClinicalTrials.gov registry record
An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies
A clinical trial, sponsored by Spectranetics Corporation.
- Completed
- Registry status
- 57
- Enrollment target
NCT02921542 is a clinical trial that has completed, run by Spectranetics Corporation. The registered enrollment target is 57 participants.
The verdict
NCT02921542 has completed, sponsored by Spectranetics Corporation.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
To evaluate vessel lumen quality (gain) and patient outcomes based on treatment with a predetermined laser treatment protocol in patients presenting with varying lesion types or morphologies: homogenous (plaques with a uniform texture-smooth and regular), heterogeneous (plaques with non-uniform texture-smooth and irregular surface), calcific (consisting of calcium) and restenotic (reoccurring narrowing of the vessel following prior treatment) associated with peripheral arterial disease (PAD).
Interventions
- DEVICE Laser Atherectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-08-15 |
| Est. Completion | 2019-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02921542
The ClinicalTrials.gov registry entry for NCT02921542 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spectranetics Corporation, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Laser Atherectomy is the first listed.
NCT02921542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02921542 about?
NCT02921542 is a clinical study titled "An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies". To evaluate vessel lumen quality (gain) and patient outcomes based on treatment with a predetermined laser treatment protocol in patients presenting with varying lesion types or morphologies: homogenous (plaques with a uniform texture-smooth and regular), heterogeneous (plaques with non-uniform text...
What is the current status of trial NCT02921542?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2016-08-15. Estimated completion is 2019-05-01.
What interventions are being tested in trial NCT02921542?
The interventions under investigation include: Laser Atherectomy (DEVICE).
Who is sponsoring clinical trial NCT02921542?
This trial is sponsored by Spectranetics Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.